SORRENTO THERAPEUTICS INC (SRNE)

US83587F2020 - Common Stock

0.3073  -0.08 (-20.26%)

After market: 0.2801 -0.03 (-8.85%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
60.32M52.90M40.00M31.40M21.20M
Minority Interest Expense
1.94M813.00K15.90M70.90M9.00M
Cost Of Goods
22.87M13.03M9.90M12.20M7.10M
Gross Profit
37.45M39.87M30.00M19.20M14.10M
Operating Expenses
395.97M441.32M274.60M278.60M164.50M
Research and Development
252.44M231.13M154.30M182.20M88.30M
Selling, General, and Administrative Expenses
197.20M196.86M116.20M103.60M63.60M
Operating Income
-358.52M-401.45M-244.60M-259.40M-150.40M
Interest Income/Expense
-79.72M-26.38M-14.10M-72.40M-55.30M
Other Income/Expense
N/A-28.00MN/A0.000.00
Non Recurring Items
-63.08M-6.70M-51.90M-27.80M-8.10M
Income Before Taxes
-529.32M-462.53M-310.60M-359.60M-213.80M
Income Tax
-33.66M-33.52M-2.00M-500.00K-6.30M
Net Income
-493.57M-428.32M-298.50M-292.10M-203.50M
EBITDA
-345.76M-388.99M-233.59M-248.41M-141.35M
 
Per Share Data
EPS Diluted Total Ops
-1.33-1.45-1.30-2.20-1.92
Non GAAP EPS
N/A-1.43-1.19-2.25-1.48
 
Statistics
Gross Profit Margin
62.09%75.37%75.00%61.15%66.51%
Profit Margin
-818.22%-809.63%-746.25%-930.25%-959.91%
Operating Profit Margin
-594.34%-758.83%-611.50%-826.11%-709.43%

All data in USD

Charts